$8.00
Manufacturer: Ukraine
Purpose: Blocks histamine receptors for allergy relief in coated tablet form.
Description
LevoCetirizine Coated Tablets 5 mg. №10
Ingredients
Active ingredient: Each tablet contains 5 mg of LevoCetirizine dihydrochloride.
Dosage
Adults and children over 6 years: Take one tablet once daily with water.
Indications
LevoCetirizine tablets are indicated for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria.
Contraindications
Do not use if: You are allergic to any of the ingredients in the product or if you have severe renal impairment.
Directions
Take as directed by your healthcare provider. Do not exceed the recommended dosage.
Scientific Evidence
LevoCetirizine, the active enantiomer of Cetirizine, has demonstrated efficacy in the treatment of allergic conditions. Studies have shown that LevoCetirizine exhibits a rapid onset of action and provides long-lasting relief from symptoms such as sneezing, itching, and nasal congestion. Research published in the Journal of Allergy and Clinical Immunology has highlighted the effectiveness of LevoCetirizine in improving quality of life for patients with allergic rhinitis.
Additional Information
LevoCetirizine is well-tolerated, with a low incidence of sedation compared to first-generation antihistamines. It is considered a second-generation antihistamine due to its selective peripheral H1 receptor antagonism, which reduces the risk of central nervous system side effects. Clinical trials have shown that LevoCetirizine is non-inferior to other second-generation antihistamines in terms of efficacy and safety profiles.
LevoCetirizine works by blocking the action of histamine, a substance in the body that causes allergic symptoms. By inhibiting histamine’s effects, LevoCetirizine helps alleviate symptoms such as itching, sneezing, and watery eyes. Unlike some older antihistamines, LevoCetirizine is less likely to cause drowsiness due to its reduced penetration of the blood-brain barrier.
In a comparative study published in the European Journal of Clinical Pharmacology, LevoCetirizine was found to have similar efficacy to other second-generation antihistamines in relieving symptoms of allergic rhinitis. The study also noted that LevoCetirizine had a favorable safety profile, making it a suitable choice for long-term management of allergic conditions.
Recent Reviews